![Gefitinib in Combination with Capecitabine as Second-Line Therapy in Patients with Advanced Colorectal Cancer (aCRC): A Phase I/II Study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)]()
Gefitinib in Combination with Capecitabine as Second-Line Therapy in Patients with Advanced Colorectal Cancer (aCRC): A Phase I/II Study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Trarbach, Tanja; Reinacher-Schick, Anke; Hegewisch-Becker, Susanne; Vanhoefer, Udo; Frieling, Thomas; Lehnert, Lasse; Schmiegel, Wolff; Graeven, Ullrich · Onkologie · 2010